Robot-assisted radical prostatectomy reduced short-term complication risk by nearly half versus open surgery. Learn more from ...
Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer Completed surveys were obtained from 685 (86%) of 797 ...
At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...
No significant differences observed in standard oncologic outcomes and quality of life at 12 weeks. Robot-assisted laparoscopic prostatectomy (RALP) results in similar functional outcomes at 12 weeks ...
The use of antiplatelet and/or anticoagulant medications has increased due to irregular diets, limited physical activity, and ...
Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...
A nerve-sparing technique (NeuroSAFE) reduced erectile dysfunction in men undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer. A year after surgery, patients randomized to ...
Prostate cancer is the most common malignant tumor in men, accounting for 29% of male neoplasm diagnoses in the United States alone. Radical prostatectomy remains the preferred treatment for localized ...
A TURBT allows examination beyond the bladder. Study findings support attempting nerve-sparing surgery in patients with confirmed high-risk prostate cancer. Nerve-sparing radical prostatectomy (NSRP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback